Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Small Cell Lung Carcinoma × 177Lu-DOTA-JR11 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Breast 1

Conditions

Small Cell Lung Carcinoma 1 Neuroendocrine Tumors 1 Breast Neoplasms 1

Interventions

Carboplatin 62 Etoposide 55 Topotecan 37 Cisplatin 33 pembrolizumab 24 atezolizumab 23 durvalumab 21 Paclitaxel 12 Nivolumab 12 rovalpituzumab tesirine 11 PM 01183 11 Pemetrexed 9 amrubicin 8 Ipilimumab 8 AMG 757 8 trilaciclib 7 Injections 7 Irinotecan 6 Drug Therapy 6 Bevacizumab 6 tremelimumab 5 EC regimen 5 Docetaxel 5 olaparib 4 chiauranib 4 budigalimab 4 MLN 8237 4 Gemcitabine 4 Dexamethasone 4 Cyclophosphamide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03773133 2022-09-13

SSTR2+

Ipsen

Phase 1/2 Terminated

9 enrolled 4 charts

Breast Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡